| Be it enacted by the People of the State of Maine as follows: |
|
| | Sec. 1. 5 MRSA §12004-G, sub-§14-D is enacted to read: |
|
| | 14-D. | Drug | Expenses | 22 MRSA |
|
| Human | Utilization | Only | §400-C |
|
| | Sec. 2. 22 MRSA c. 108 is enacted to read: |
|
| MEDICAID DRUG UTILIZATION AND |
|
| | The Legislature recognizes that outpatient prescription drugs | are an essential component of patient care.__A formulary, prior | authorization process or treatment protocol pertaining to a state | Medicaid program, chapter 855, the elderly low-cost drug program, | section 254 or any other state medical assistance program may not | be used to make coverage and payment decisions relating to a | practitioner's lawful use of prescription drugs unless it meets | the requirements of this chapter.__Any rules adopted before or | after the effective date of this chapter by the Department of | Human Services are void to the extent that they are inconsistent | with this chapter. |
|
| | As used in this chapter, unless the context otherwise | indicates, the following terms have the following meanings. |
|
| | 1.__Board.__"Board" means the Drug Utilization Review Board | established under section 400-C. |
|
| | 2.__Committee.__"Committee" means the Pharmacy and | Therapeutics Committee established under section 400-E. |
|
| | 3.__Compendia.__"Compendia" for a drug means the "American | Hospital Formulary Services Drug Information," or its successor, | the "United States Pharmacopeia - Drug Information," or its | successor, peer-reviewed medical literature and clinical | information submitted to a state Medicaid agency by the | pharmaceutical research company that developed the drug and that | is registered with the Federal Food and Drug Administration as | the drug distributor. |
|
|